Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Intangibles (2016 - 2025)

Historic Intangibles for Ascendis Pharma A (ASND) over the last 14 years, with Q4 2025 value amounting to $4.3 million.

  • Ascendis Pharma A's Intangibles rose 34.13% to $4.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.3 million, marking a year-over-year increase of 34.13%. This contributed to the annual value of $4.2 million for FY2025, which is 259.33% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Intangibles of $4.3 million as of Q4 2025, which was up 34.13% from $4.4 million recorded in Q3 2025.
  • Ascendis Pharma A's Intangibles' 5-year high stood at $6.8 million during Q1 2021, with a 5-year trough of $4.1 million in Q1 2025.
  • For the 5-year period, Ascendis Pharma A's Intangibles averaged around $5.2 million, with its median value being $5.0 million (2022).
  • In the last 5 years, Ascendis Pharma A's Intangibles skyrocketed by 7526.42% in 2021 and then crashed by 3091.86% in 2024.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Intangibles stood at $6.5 million in 2021, then decreased by 10.82% to $5.8 million in 2022, then grew by 6.82% to $6.2 million in 2023, then plummeted by 30.92% to $4.3 million in 2024, then rose by 0.34% to $4.3 million in 2025.
  • Its Intangibles was $4.3 million in Q4 2025, compared to $4.4 million in Q3 2025 and $4.3 million in Q2 2025.